Literature DB >> 17371969

Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice.

Kevin N Couper1, Daniel G Blount, J Brian de Souza, Isabelle Suffia, Yasmine Belkaid, Eleanor M Riley.   

Abstract

Investigation of the role of regulatory T cells (Treg) in model systems is facilitated by their depletion using anti-CD25 Abs, but there has been considerable debate about the effectiveness of this strategy. In this study, we have compared the depletion and repopulation of CD4+CD25+Foxp3+ Treg in uninfected and malaria-infected mice using 7D4 and/or PC61 anti-CD25 Abs. We find that numbers and percentages of CD25(high) cells, but not Foxp3+ cells, are transiently reduced after 7D4 treatment, whereas treatment with PC61 alone or in combination with 7D4 (7D4 plus PC61) reduces but does not eliminate Foxp3+ cells for up to 2 wk. Importantly, all protocols fail to eliminate significant populations of CD25-Foxp3+ or CD25(low)Foxp3+ cells, which retain potent regulatory capacity. By adoptive transfer we show that repopulation of the spleen by CD25(high)Foxp3+ cells results from the re-expression of CD25 on peripheral populations of CD25-Foxp3+ but not from the conversion of peripheral Foxp3-) cells. CD25(high)Foxp3+ repopulation occurs more rapidly in 7D4-treated mice than in 7D4 plus PC61-treated mice, reflecting ongoing clearance of emergent CD25+Foxp3+ cells by persistent PC61 Ab. However, in 7D4 plus PC61-treated mice undergoing acute malaria infection, repopulation of the spleen by CD25+Foxp3+ cells occurs extremely rapidly, with malaria infection driving proliferation and CD25 expression in peripheral CD4+CD25-Foxp3+ cells and/or conversion of CD4+CD25-Foxp3- cells. Finally, we reveal an essential role for IL-2 for the re-expression of CD25 by Foxp3+ cells after anti-CD25 treatment and observe that TGF-beta is required, in the absence of CD25 and IL-2, to maintain splenic Foxp3+ cell numbers and a normal ratio of Treg:non-Treg cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371969      PMCID: PMC2235934          DOI: 10.4049/jimmunol.178.7.4136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

2.  In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro.

Authors:  Ludger Klein; Khashayarsha Khazaie; Harald von Boehmer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

3.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

4.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

Authors:  Rinee Mukherjee; Pratibha Chaturvedi; Hui-Yu Qin; Bhagirath Singh
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

6.  Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells.

Authors:  Hajime Hisaeda; Yoichi Maekawa; Daiji Iwakawa; Hiroko Okada; Kunisuke Himeno; Kenji Kishihara; Shin-ichi Tsukumo; Koji Yasutomo
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

7.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

8.  Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells.

Authors:  Sayuri Yamazaki; Tomonori Iyoda; Kristin Tarbell; Kara Olson; Klara Velinzon; Kayo Inaba; Ralph M Steinman
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

9.  Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.

Authors:  Lucy S K Walker; Anna Chodos; Mark Eggena; Hans Dooms; Abul K Abbas
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

10.  Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens.

Authors:  Isabelle J Suffia; Stacie K Reckling; Ciriaco A Piccirillo; Romina S Goldszmid; Yasmine Belkaid
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  67 in total

1.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

2.  Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.

Authors:  Cong Wu; Yi Zhang; Yingming Jiang; Quanxing Wang; Yao Long; Chunmei Wang; Xuetao Cao; Guoyou Chen
Journal:  Cell Mol Immunol       Date:  2013-07-22       Impact factor: 11.530

Review 3.  Regulatory T cells in AKI.

Authors:  Gilbert R Kinsey; Rahul Sharma; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

4.  Partial Depletion of Regulatory T Cells Enhances Host Inflammatory Response Against Acute Pseudomonas aeruginosa Infection After Sepsis.

Authors:  Zhi-Qiang Hu; Yong-Ming Yao; Wei Chen; Jia-Lan Bian; Lin-Jun Zhao; Long-Wang Chen; Guang-Liang Hong; Zhong-Qiu Lu; Guang-Ju Zhao
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

5.  Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation.

Authors:  L Faustino; D M Fonseca; E B Florsheim; R R Resende; A P Lepique; E Faquim-Mauro; E Gomes; J S Silva; H Yagita; M Russo
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

6.  Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection.

Authors:  Kevin N Couper; Paula A Lanthier; Georgia Perona-Wright; Lawrence W Kummer; Wangxue Chen; Stephen T Smiley; Markus Mohrs; Lawrence L Johnson
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 7.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

8.  Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria.

Authors:  Michael Walther; David Jeffries; Olivia C Finney; Madi Njie; Augustine Ebonyi; Susanne Deininger; Emma Lawrence; Alfred Ngwa-Amambua; Shamanthi Jayasooriya; Ian H Cheeseman; Natalia Gomez-Escobar; Joseph Okebe; David J Conway; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

9.  Reduction of Foxp3+ cells by depletion with the PC61 mAb induces mortality in resistant BALB/c mice infected with Toxoplasma gondii.

Authors:  Eda Patricia Tenorio; Jonadab Efraín Olguín; Jacquelina Fernández; Pablo Vieyra; Rafael Saavedra
Journal:  J Biomed Biotechnol       Date:  2009-12-13

10.  Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.

Authors:  Anja Scholzen; Diana Mittag; Stephen J Rogerson; Brian M Cooke; Magdalena Plebanski
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.